Agilon Health, Inc. (AGL) - What Are Brokerages Thinking About This Stock?

Key Points

• Analyst consensus is “Hold”: Among 14 covering firms, six rate Agilon Health a buy, six a hold and two a sell. The average 12-month price target is $102.25, with targets ranging from $112 to $146 among recently updated ratings.
• Agilon reported a quarterly earnings beat: The company posted $1.04 in earnings per share versus the $0.14 consensus estimate, while revenue reached $1.49 billion against expectations of $1.45 billion. Analysts nevertheless expect a full-year loss of approximately $2.90 per share.
• Institutional interest has increased: Several investors, including State Street, Rubicon Founders and Tidal Investments, recently initiated positions in Agilon Health. The stock opened at $84.37 and has a notably high beta of 2.98, indicating substantial volatility.

Agilon Health, Inc. (NYSE:AGL - Get Free Report) has received an average recommendation of "Hold" from the fourteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and six have given a buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $102.25.

A number of research firms have weighed in on AGL. Truist Financial set a $112.00 target price on shares of Agilon Health and gave the stock a "hold" rating in a research note on Thursday, August 6th. Benchmark restated a "buy" rating and issued a $140.00 price target (up from $95.00) on shares of Agilon Health in a research report on Thursday, August 6th. Robert W. Baird set a $116.00 price objective on Agilon Health in a research report on Thursday, August 6th. Wells Fargo & Company reissued an "overweight" rating and set a $146.00 price objective (up from $141.00) on shares of Agilon Health in a research note on Tuesday, August 11th. Finally, Sanford C. Bernstein upgraded Agilon Health from a "market perform" rating to an "outperform" rating and upped their target price for the company from $86.00 to $125.00 in a report on Tuesday, September 15th.

Agilon Health Price Performance

NYSE:AGL opened at $84.37 on Friday. Agilon Health has a 12 month low of $7.48 and a 12 month high of $133.04. The stock has a 50 day moving average of $87.75 and a two-hundred day moving average of $64.87. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.07. The firm has a market cap of $1.42 billion, a P/E ratio of -5.91 and a beta of 2.98.

Agilon Health (NYSE:AGL - Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.90. The business had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.45 billion. Agilon Health had a negative return on equity of 119.38% and a negative net margin of 3.92%. On average, analysts expect that Agilon Health will post -2.90 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Agilon Health

Hedge funds and other institutional investors have recently bought and sold shares of the company. Tidal Investments LLC purchased a new position in Agilon Health in the second quarter worth approximately $1,405,000. Rubicon Founders LLC acquired a new stake in shares of Agilon Health during the 2nd quarter worth about $11,290,448. State Street Corp acquired a new stake in shares of Agilon Health during the 2nd quarter worth about $30,024,000. Ellsworth Advisors LLC acquired a new stake in shares of Agilon Health during the 3rd quarter worth about $809,000. Finally, Great Lakes Advisors LLC purchased a new stake in Agilon Health in the 2nd quarter valued at about $702,000.

Agilon Health Company Profile

Agilon Health, Inc is a healthcare company that partners with independent primary care physicians to support the transition from fee-for-service medicine to value-based care. The company works with physician practices serving primarily older adults enrolled in Medicare Advantage and helps them manage the cost, quality and coordination of care for their patient populations.

Agilon provides a technology-enabled platform that includes population health analytics, clinical and administrative support, care coordination resources and practice-management capabilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.